Effect of intramural, subserosal, and submucosal uterine fibroids on the outcome of assisted reproductive technology treatment [PDF]
, 1998 Talia Eldar‐Geva +5 more
openalex +1 more source
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.
New England Journal of Medicine, 2008 R. Schlenk +13 more
semanticscholar +1 more source
Molecular Oncology, EarlyView.This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau +9 more
wiley +1 more source
Multi-level treatment outcome evaluation in adolescents with autism spectrum disorder. [PDF]
Child Adolesc Psychiatry Ment HealthAuer GA +3 more
europepmc +1 more source
Social Support Resource Outcomes for the Clients of Two Assertive Community Treatment Teams
, 1994 Joseph Walsh
openalex +2 more sources
Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina [PDF]
, 1996 Henry J. Dargie, Ian Ford, Kim Fox
openalex +1 more source
A nucleotide‐independent, pan‐RAS‐targeted DARPin elicits anti‐tumor activity in a multimodal manner
Molecular Oncology, EarlyView.We report a Designed Ankyrin Repeat Protein that binds and inhibits RAS proteins, which serve as central cell signaling hubs and are essential for the progression of many cancers. Its unique feature is that it does not discriminate between different RAS isoforms or mutations and is capable of binding to RAS in both its active (GTP‐bound) and inactive ...
Jonas N. Kapp +13 more
wiley +1 more source
Autoantibody spark response predicts treatment outcome in patients receiving chemoradiation followed by durvalumab therapy. [PDF]
Sci RepMori T +10 more
europepmc +1 more source
B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome [PDF]
, 1999 TG Gross +7 more
openalex +1 more source
Molecular Oncology, EarlyView.C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald +18 more
wiley +1 more source